QUALITY BY DESIGN- A NEW APPROACH TO DRUG DEVELOPMENT
Journal Title: International Journal of Drug Regulatory Affairs - Year 2015, Vol 3, Issue 2
Abstract
Quality by design is an essential part of the modern approach to pharmaceutical quality. A new approach to drug development could increase efficiencies, provide regulatory relief and flexibility, and offer important business benefits throughout the product’s life cycle. QbD has become the answer to assist both industry and FDA to move towards a more scientific, risk based, holistic and proactive approach to pharmaceutical development.
Authors and Affiliations
Dey Rumel, Chowdhury DR
Keywords
Related Articles
- EP ID EP339347
- DOI -
- Views 125
- Downloads 0
HARMONIZATION & ADVANCEMENT IN PHARMACEUTICAL INDUSTRY
The urgent requirement to rationalize and harmonize regulation was impelled by instance of rising cost of Health care, Research and Development and need to meet the public requirement to approach for the safe and efficac...
Covering Global Pharmaceutical Regulations in a Quality System
This article describes how to address compliance with a wide range of applicable regulations within a company’s quality system. The focus is on the way regulatory intelligence can be obtained and subsequently be interpre...
STATUS OF A T POLYMORPHISM IN EXON II OF KINASE INSERT DOMAIN GENE IN WOMEN WITH PREMATURE OVARIAN FAILURE
Ovarian failure is defined as cessation of ovarian function under the age of 40 and it is characterized by amenorrhea hypo estrogenism and elevated gonadotrophin serum levels leading to infertility. Ovarian failure affec...
A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries
To ensure quality, efficacy, and safety of drugs is the prime objective of any country and respective drug regulatory authority. Countries have their own regulatory setup to ensure the proper execution of drug regulatory...
SOFTWARE AS MEDICAL DEVICE
The use of software in a medical device allows the manufacturer to concentrate on the application needed to run device-specific functions. The medical device manufacturer using software generally neglect software life cy...